Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-12-18: Form 6-K; Period of report 2024-12-18; Description 6-K; Document form6k_121824.htm.
- 2024-12-13: Form 6-K; Period of report 2024-12-13; Description 6-K; Document form6k_121324.htm.
- 2024-12-02: Form 6-K; Period of report 2024-12-02; Description 6-K; Document form6k_120224.htm.
- 2024-10-31: Form 6-K; Period of report 2024-10-31; Description 6-K; Document form6k-3_103124.htm.